SG
NTLA icon

StoneX Group’s Intellia Therapeutics NTLA Stock Holding History

StoneX Group’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,185
Closed -$227K – 417
2023
Q3 		$227K Sell
7,185
-242
-3% -$9.39K 0.13% 250
2023
Q2 		$303K Buy
7,427
+42
+0.6% +$1.7K 0.17% 174
2023
Q1 		$275K Sell
7,385
-239
-3% -$9.37K 0.16% 196
2022
Q4 		$266K Buy
+7,624
New +$363K 0.04% 329
2022
Q2 		– Sell
-7,515
Closed -$546K – 670
2022
Q1 		$546K Sell
7,515
-815
-10% -$69K 0.05% 291
2021
Q4 		$985K Sell
8,330
-1,671
-17% -$209K 0.11% 175
2021
Q3 		$1.34M Sell
10,001
-1,791
-15% -$271K 0.19% 113
2021
Q2 		$1.91M Sell
11,792
-1,085
-8% -$84.5K 0.28% 71
2021
Q1 		$1.03M Sell
12,877
-990
-7% -$66.5K 0.19% 107
2020
Q4 		$754K Sell
13,867
-515
-4% -$18.7K 0.17% 130
2020
Q3 		$286K Sell
14,382
-100
-0.7% -$2.08K 0.09% 238
2020
Q2 		$304K Sell
14,482
-500
-3% -$8.49K 0.12% 212
2020
Q1 		$183K Hold
14,982
– – 0.1% 229
2019
Q4 		$220K Sell
14,982
-1,335
-8% -$18.6K 0.09% 272
2019
Q3 		$218K Sell
16,317
-535
-3% -$8.53K 0.14% 226
2019
Q2 		$276K Sell
16,852
-700
-4% -$11K 0.18% 180
2019
Q1 		$300K Sell
17,552
-443
-2% -$6.6K 0.23% 156
2018
Q4 		$246K Sell
17,995
-1,803
-9% -$33.5K 0.24% 164
2018
Q3 		$567K Sell
19,798
-697
-3% -$20.3K 0.42% 78
2018
Q2 		$561K Buy
20,495
+875
+4% +$21.2K 0.48% 68
2018
Q1 		$414K Buy
19,620
+1,255
+7% +$30.9K 0.4% 89
2017
Q4 		$353K Buy
+18,365
New +$424K 0.37% 103

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

StoneX Group's NTLA Position: Q4 2023 in Review

StoneX Group sold out of Intellia Therapeutics (NTLA) in Q4 2023, closing a stake of 7,185 shares — an estimated $227K sold.

StoneX Group first reported a position in NTLA in Q4 2017 and held it in 22 quarters. The position peaked at $1.91M in Q2 2021. 292 funds tracked by Wall St. Rank hold NTLA as of Q4 2023.

  • StoneX Group reported no remaining Intellia Therapeutics position as of Q4 2023 after selling out during the quarter.
  • StoneX Group sold 7,185 Intellia Therapeutics shares in Q4 2023, an estimated $227K.
  • StoneX Group first reported a position in Intellia Therapeutics in Q4 2017 and held it in 22 quarters.
  • StoneX Group's Intellia Therapeutics position peaked at $1.91M in Q2 2021.
  • 292 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2023.

Based on StoneX Group's 13F filing for Q4 2023, filed 12 Feb 2024.